Meningococcal Immunization Against Gonococcal Infection Clinical Trial
$2,108,870Y01FY2024AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Abstract
To support a phase II randomized, placebo-controlled study, to assess efficacy of meningococcal Group B vaccine (Bexsero©, GSK) in preventing gonorrhea.
View original record on NIH RePORTER →